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Summary 8 
RNA binding proteins (RBPs) regulate all aspects in the life cycle of RNA molecules. To 9 
elucidate the elements that guide RNA specificity, regulatory mechanisms and functions of 10 
RBPs, methods that identify direct endogenous protein-RNA interactions are particularly 11 
valuable. UV Crosslinking and Immunoprecipitation (CLIP) purifies short RNA fragments that 12 
crosslink to a specific protein, and then identifies these fragments by sequencing. When 13 
combined with high-throughput sequencing, CLIP can produce transcriptome-wide maps of 14 
RNA crosslink sites. The protocol is comprised of several dozen biochemical steps, and 15 
improvements made over the last 15 years have increased its resolution, sensitivity and 16 
convenience. Adaptations of CLIP are also emerging in the epitranscriptomic field to map the 17 
positions of RNA modifications accurately. Here, we describe the rationale for each step in the 18 
protocol and discuss the impact of variations to help users determine the most suitable option.  19 
Main Text 20 
Introduction 21 
RNA binding proteins (RBPs) play a role in diverse mechanisms of RNA regulation, from pre-22 
mRNA splicing and 3’ end processing to RNA modification, translation, stability and 23 
localisation. Most RBPs are localised at specific cellular locations, where they are presented 24 
with a unique composition of potential RNA targets and other RBPs that affect the binding 25 
patterns through competitive or cooperative interactions. Over a thousand human proteins 26 
have been shown to crosslink to RNA by mass spectrometry studies, including RNA enzymes, 27 
and proteins that lack canonical RNA-binding domains (Baltz et al., 2012; Castello et al., 28 
2012). In order to disentangle the diverse roles of these proteins, it is necessary to map their 29 
in vivo binding sites across the transcriptome. 30 
Several methods can be used to identify the endogenous protein-RNA interactions with 31 
variable specificity and sensitivity. The first method developed for this purpose used antibodies 32 
against the spliceosomal Sm proteins (lupus autoimmune sera) to identify the small nuclear 33 
RNAs, which interact with Sm proteins within the abundant spliceosomal small nuclear 34 
ribonucleoproteins (Lerner and Steitz, 1979). This method, later referred to as RIP (for 35 
RNP/RNA immunoprecipitation), relies on immunoprecipitation (IP) of an RBP under 36 
conditions that preserve ribonucleoprotein complexes (RNPs) (Niranjanakumari et al., 2002). 37 
RNPs are preserved either due to mild washing conditions during IP, or by exposing cells to 38 
formaldehyde, which crosslinks protein-protein and protein-RNA interactions. Subsequent 39 
studies used microarrays for transcriptomic analysis of the purified RNAs, and the resulting 40 
method has been referred to as RIP-chip (Keene et al., 2006; Tenenbaum et al., 2000). In 41 
2010, RIP was combined with high-throughput sequencing, and termed RIP-seq (Zhao et al., 42 
2010). While RIP can identify abundant RNAs bound by an RNP, it is not well suited to studies 43 
of direct protein-RNA contacts. This is because it preserves protein-protein interactions, and 44 
thus can purify multiple RBPs in complex with their bound RNAs. Under some conditions it 45 
can also identify interactions that result from in vitro re-associations (Mili and Steitz, 2004). 46 
Therefore, methods with increased specificity for direct RNA binding sites are needed, 47 
especially if one wishes to identify binding sites in lowly abundant RNAs. 48 
To identify the position of direct protein-RNA interactions, it is crucial to use a method that 49 
preserves endogenous protein-RNA contacts, while ensuring that only a single specific RBP 50 
is purified. Crosslinking and immunoprecipitation (CLIP) was developed for this purpose by 51 
exploiting zero-length covalent protein-RNA crosslinking and RNA fragmentation (Ule et al., 52 
2003). This enables CLIP to purify RNAs bound to a specific RBP under conditions that are 53 
stringent enough to prevent co-purification of additional RBPs or free RNAs. Moreover, since 54 
only the RNA fragments that are crosslinked to the RBP are isolated, CLIP can identify the 55 
position of the direct RNA binding sites. 56 
Initially, CLIP relied on Sanger sequencing to identify 340 sequences corresponding to RNA 57 
interactions of splicing factors Nova1 and Nova2 in mouse brain (Ule et al., 2003). 244 of 58 
these sequences were intronic or intergenic, confirming that CLIP is sensitive enough to 59 
efficiently identify binding sites within low-abundance RNAs. Abundant RNAs such as rRNAs 60 
were absent, underlining the specificity of the method. Even though the sequences were only 61 
approximately 50nt long, they contained on average four Nova-binding motifs, further 62 
confirming the high specificity of CLIP data. Several of the sequences were located next to 63 
alternative exons that turned out to be regulated by Nova proteins, thus demonstrating the 64 
capacity of CLIP to identify the position of functionally important binding sites. 65 
Since the original study, multiple variant protocols have been derived to improve the conditions 66 
of RNA fragmentation, RBP purification and cDNA library preparation (Ule et al., 2005), 67 
establish denaturing conditions for RBP purification (Granneman et al., 2009),  employ high-68 
throughput sequencing (Licatalosi et al., 2008; Yeo et al., 2009), determine the position of 69 
crosslink sites at nucleotide resolution (Hafner et al., 2010; König et al., 2010), and increase 70 
the efficiency and convenience of the protocol (Table 1, Table 2). Since RIP or ChIP were 71 
originally combined with microarray readout, the addition of ‘-seq’ (e.g. RIP-seq) was needed 72 
to specify the use of sequencing as opposed to of microarrays. In contrast, the original CLIP 73 
and all the derived variants rely on sequencing. We therefore use the term ‘CLIP’ to refer 74 
generically to all protocols that purify covalently crosslinked protein-RNA complexes and then 75 
sequence the bound RNA fragments. 76 
We describe the core steps of CLIP, the rationale behind each available variation, and their 77 
likely effects on the sensitivity, resolution, specificity or convenience of different protocols (Fig. 78 
1, Table 2). For comparative purpose, we also provide an overview of the steps that are 79 
employed by each of the 28 published protocols (Table S1). We outline the basic approaches 80 
to assess the sensitivity and specificity of CLIP data, while a comprehensive summary of 81 
computational methods for CLIP data analysis is reviewed in more detail elsewhere 82 
(Chakrabarti et al., 2017). We conclude with a discussion of the quality control analyses, and 83 
of the opportunities to apply CLIP to new purposes. 84 
Core steps of CLIP 85 
Although most steps of CLIP have undergone several variations, the core concepts behind 86 
each of the steps and the order of the steps remain largely the same (Fig. 1, Table 1, Table 87 
2). The variants either modify the way the steps are performed, add or omit some of the steps, 88 
in order to increase the efficiency or convenience of the protocol. A central aspect of the 89 
experimental design common to all protocols is the use of appropriate negative controls, which 90 
is important for interpreting the specificity of the purification procedure. The ideal control is to 91 
perform the same purification from cells where the RBP is absent, such as knockout cells, or 92 
when using tag-based purification, cells that do not express a tagged protein (Huppertz et al., 93 
2014; Ule et al., 2005). As an alternative, non-specific serum or IgG can be used for IP. It is 94 
also valuable to immunoprecipitate the RBP from non-crosslinked cells. If CLIP conditions are 95 
well optimised, these controls should not produce any clearly detectable signal during SDS-96 
PAGE analysis, and sequencing of their libraries should result in at least 100-fold fewer unique 97 
cDNAs compared to the specific experiments (König et al., 2010). 98 
Covalent crosslinking of protein-RNA contacts 99 
Most variants of CLIP exploit the capacity of ultraviolet (UV) light to promote formation of 100 
covalent bonds between RBPs and their direct RNA binding sites (Table S1). Unlike the 101 
formaldehyde crosslinking that is used in chromatin immunoprecipitation (ChIP) and some 102 
variants of RIP, UV does not crosslink proteins to each other. UV crosslinking requires direct 103 
contact between an amino acid and a nucleobase, and therefore ensures that only direct 104 
protein-RNA interactions are preserved, and the high strength of the covalent bond allows 105 
further stringent purification of individual RBPs and their crosslinked RNA fragments. 106 
The original and most later variants of CLIP exposes cells or triturated tissues to the UV-C 107 
wavelength (254nm), which can crosslink RBPs to their bound RNAs without the need for any 108 
additional pre-treatment (Ule et al., 2003). Cells are placed on ice during the short period of 109 
crosslinking in order to avoid any cellular responses, for instance the induction of UV-induced 110 
DNA damage response. The recommended crosslinking procedure for cells in a monolayer 111 
takes 40 seconds (using an energy of 150mJ/cm2) (König et al., 2010); this short period allows 112 
a snapshot of the interactions to be captured, thus enabling CLIP to monitor changes in RNP 113 
assembly that occur upon a response to extracellular signals or other treatments (Schor et al., 114 
2012). A higher total energy can be employed for tissues or cells in suspension, where multiple 115 
rounds of UV exposure with intermittent mixing are needed in order to obtain evenly-116 
distributed crosslinking throughout the sample. Some protocols employ high UV-C 117 
crosslinking energies also for cells in a monolayer, since this increases crosslinking efficiency 118 
and thus sensitivity of CLIP, but this can also increase a cellular response to UV-induced 119 
damage, and the propensity of multiple RBPs to crosslink on the same RNA fragment, thus 120 
risking co-purification of contaminating RBPs. In cases of proteins that do not crosslink well to 121 
RNA, digestion optimized (DO)-RIP-seq could also be employed to identify fragments of RNAs 122 
that are proximal to the protein of interest (Nicholson et al., 2017). 123 
PAR-CLIP introduces a variation in the crosslinking strategy (Hafner et al., 2010) (Table 1). 124 
Cells are pre-incubated with photoactivatable ribonucleosides 4-thiouridine (4SU) or 6-125 
thioguanosine (6SG), which enable protein-RNA crosslinking to be performed with UV-A 126 
wavelength (365nm). Mass spectroscopy analyses indicate two thirds of RBPs efficiently 127 
crosslink with either the standard UV-C (CL) or with the 365nm (PAR-CL), but twice as many 128 
RBPs (24% of the interactome) were identified only by CL compared with 12% for PAR-CL 129 
(Castello et al., 2012). So far, only one mass spectrometry study has compared the CL and 130 
PAR-CL, and therefore the features of RBPs that confer the differential efficiency of these two 131 
crosslinking methods remain unclear. The use of 4SU or 6SG restricts crosslinking to a single 132 
base, and therefore the crosslinking efficiency might also depend on the proximity of these 133 
bases to the binding site. The PAR-CL protocol is limited to biological systems where the 134 
photoactivatable nucleosides can be efficiently incorporated. Incorporation of 4SU through 135 
liquid culture for C. elegans or intraperitoneal injection for mouse has enabled studies in model 136 
organisms, however the incorporation rates are lower than in HEK cells in culture (Jungkamp 137 
et al., 2011; Kim et al., 2014), hence they have drawbacks in sensitivity.  Moreover, prolonged 138 
preincubation with 6SG (and to a lesser extent 4SU) could cause cellular toxicity, and therefore 139 
care needs to be taken to monitor the cellular response to these ribonucleosides (Burger et 140 
al., 2013; Huppertz et al., 2014). Application of pulsed 4SU has been used in techniques for 141 
tagging and enriching nascent RNAs for sequencing (Windhager et al., 2012), and this 142 
concept could be combined with CLIP to study the patterns of co-transcriptional RNP 143 
assembly on newly transcribed RNAs. 144 
The third approach to crosslinking is introduced by m5C-miCLIP, which exploits a mutant 145 
NSun2 RNA methylase enzyme for transcriptome-wide mapping of 5-methylcytosine (m5C) 146 
modification sites (George et al., 2017; Hussain et al., 2013) (Table 1). This mutant enzyme 147 
is uncapable of completing the methylation, and instead covalently attaches to the RNA base 148 
at the site of modification. This approach is combined with iCLIP, which has been developed 149 
to amplify cDNAs that truncate at the crosslink site, thus enabling nucleotide-resolution 150 
mapping of the crosslink sites (König et al., 2010) (Table 1). As expected, the crosslink sites 151 
identified by m5C-miCLIP are enriched in cytosines, rather than uridines that are most 152 
common when using UV-C crosslinking in iCLIP (Sugimoto et al., 2012). 153 
Finally, proteins can be crosslinked to RNA with UV light in vitro. This has been exploited by 154 
variant protocols aimed at studies of RNA methylation, such as m6A-miCLIP (Chen et al., 155 
2015; George et al., 2017; Ke et al., 2015; Linder et al., 2015) (Table 1). Here, RNA is purified 156 
and partially fragmented, then incubated with an antibody recognising the N6-157 
Methyladenosine (m6A) modification. Subsequently, UV-C crosslinking is used to form a 158 
covalent bond between the antibody and the modified base. The antibody-RNA complex is 159 
then captured on protein A/G magnetic beads, and the sample continues to the on-bead 160 
adapter ligation and the rest of the iCLIP protocol. Enrichment of the expected sequence motif 161 
at the crosslink sites confirmed the high positional accuracy of the resulting data (Linder et al., 162 
2015). 163 
Cell lysis 164 
In almost all CLIP derived protocols, a stringent buffer containing ionic detergents is used for 165 
cell lysis, which disrupts most protein-protein and protein-RNA interactions. This increases the 166 
accessibility of RNA and allows unbiased RNase fragmentation, by decreasing the chance 167 
that long RNA binding sites remain protected by large RNPs. It also minimises the chance of 168 
co-purifying multiple associated RBPs during later immunoprecipitation, thus helping to ensure 169 
data specificity.  170 
In addition, with methods where the whole cell lysate is used as the input, the proportions of 171 
the different types of RNAs in the resulting data can inform on the cellular distribution of the 172 
RBP. For example, predominance of intronic reads can indicate that the RBP primarily binds 173 
to nascent RNAs on chromatin, whereas enrichment of exonic and junction-spanning reads 174 
indicates that the RBP primarily binds to spliced mRNAs in the cytoplasm. For studies where 175 
the interactome of specific subcellular compartmentalisation is of interest, cell lysis can be 176 
adapted to accommodate the fractionation of sub-cellular compartments. The first protocol 177 
developed for this purpose produced CLIP data from nuclear, cytosolic and polysome fractions 178 
(Sanford et al., 2008). More recently the Fr-iCLIP method has been developed, which 179 
fractionates the nucleus into chromatin and nucleoplasm before proceeding to iCLIP (Brugiolo 180 
et al., 2017) (Table 1). 181 
RNA fragmentation 182 
RNA fragmentation is crucial to avoid co-purifying multiple RBPs that crosslink to the same 183 
RNAs, and to provide insight into the position of RNA binding sites, since the RNA fragment 184 
contains the crosslink site. The variation in RNase concentration is unlikely to lead to major 185 
changes in the resulting data, and enriched motifs at the crosslink sites are expected to remain 186 
the same within a range of RNase concentrations (Van Nostrand et al., 2016). However, 187 
analysis of the crosslink sites identified by various PTBP1 iCLIP experiments revealed that 188 
variations in RNase concentrations can lead to changes at the ends of the cDNA inserts, which 189 
correspond to the sites of RNase cleavage (Haberman et al., 2017). Such constraints at the 190 
ends of the cDNA inserts can impact binding site assignment, especially in the case of long 191 
binding sites of RBPs, where appropriate optimisation of RNA fragmentation was found to be 192 
particularly important. 193 
Overdigestion results in short RNA fragments, and thus a narrow distribution of cDNA sizes. 194 
This can introduce constraints at the ends of the cDNA insert due to the preferred pattern of 195 
RNase cleavage, and produce short cDNAs that are less likely to map uniquely to the repetitive 196 
regions of the genome (Haberman et al., 2017). On the other hand, insufficient RNA digestion 197 
can lead to co-purification of additional RBPs that bind to the long RNA fragments together 198 
with the immunoprecipitated RBP. This has been exploited in studies which identify RNA-199 
dependent protein interactors of the RBP-of-interest (Botti et al., 2017; Brannan et al., 2016; 200 
Flury et al., 2014; Klass et al., 2013). Most RNAs contain a large number of binding sites for 201 
many RBPs, hence long RNA fragments could be crosslinked to multiple RBPs at different 202 
positions. Thus, by increasing the presence of co-purified RBPs, long RNA fragments could 203 
decrease the specificity of the final data. An optimal RNA size range of 30-200 nt can be 204 
achieved with a short incubation of the lysate with a low RNase concentration, which can be 205 
optimised by using the visualisation of protein-RNA complexes after SDS-PAGE separation 206 
upon a titration of RNase conditions (Huppertz et al., 2014; Ule et al., 2005). This optimisation 207 
is important especially when starting experiments with a new RBP, or from a new type of cell 208 
or tissue, or when testing new reagent stock.  209 
While most protocols perform RNase treatment in the lysate, several protocols employ on-210 
bead RNase treatment. For example, PAR-CLIP and sCLIP protocols digest with RNase in 211 
the lysate as well as after IP (Hafner et al., 2010; Kargapolova et al., 2017) (Table 1). Zarnegar 212 
and colleagues compared the effects of performing the RNase digestion step either in the 213 
lysate, or on-bead after immunoprecipitation. By using the infrared visualisation in irCLIP 214 
(Table 1), the amount of adapter-ligated RNA-protein complexes can be examined on the 215 
membrane after SDS-PAGE, which showed that the on-bead approach resulted in the highest 216 
signal (Zarnegar et al., 2016). However, it is unclear whether this reflects higher efficiency, or 217 
an increase in non-specific signal. For example, the presence of non-fragmented RNAs during 218 
IP could stabilise large RNPs, leading to formation of multiprotein complexes that would be 219 
harder to perturb with later washing steps. While this possibility remains to be examined, the 220 
low density of binding motifs at sites assigned by PTBP1 irCLIP indicates compromised 221 
specificity for this experiment (Haberman et al., 2017). 222 
CLIP protocols also differ in the choice of RNase enzymes. The original CLIP used RnaseT1 223 
and RNase A, while the original PAR-CLIP used RnaseT1 and Mnase. These nucleases have 224 
sequence preferences in their cleavage patterns, and extensive digestion can lead to biased 225 
assignment of binding sites from CLIP protocols (Kishore et al., 2011). The iCLIP protocol 226 
introduced the use of RNase I, which is not known to have any nucleotide preferences, and is 227 
thus expected to introduce minimal sequence bias at both ends of RNA fragments (König et 228 
al., 2010). The irCLIP protocol also introduced the use of S1 nuclease, which leaves a 3’OH 229 
instead of a 3’ phosphate at the ends of RNA fragments (Zarnegar et al., 2016). This makes 230 
the 3’ end dephosphorylation step unnecessary, which otherwise needs to precede the 231 
adapter ligation step. S1 nuclease is a relatively inefficient enzyme on RNA, and therefore we 232 
find its treatment compatible only with the on-bead digestion (data not shown). 233 
It is a common misconception that the RNA fragments in CLIP are a signature of RNase 234 
protection. Unlike formaldehyde crosslinking, during which protein-protein interactions are 235 
also crosslinked, UV crosslinking is specific to protein-RNA contacts, and therefore does not 236 
stabilise large RNPs. Instead, CLIP intentionally uses stringent lysis conditions in order to 237 
perturb most native protein-RNA interactions. Thus, the covalent crosslinking normally 238 
remains as the only link between the RBP and the RNA, unless the RBP participates in an 239 
RNP that is unusually stable. If a signature of RNase protection is desired, it would be possible 240 
to lyse the cells under mild conditions that preserve native protein-RNA interactions, perform 241 
RNase fragmentation, and then continue to CLIP with more stringent buffers later during 242 
immunoprecipitation. Alternatively, ribonuclease-mediated protein footprinting methods such 243 
PIP-seq (Silverman et al., 2014) and RIP-iT-Seq (Singh et al., 2014) could be used. 244 
Bead-based purification of the RBP-RNA complex 245 
CLIP allows the purification of RBPs from cells and tissues with stringent immunoprecipitation 246 
conditions, including the use of ionic detergents in the lysis and washing buffers, and the use 247 
of high salt washes. Purification of endogenous RBPs normally requires that antibodies are 248 
available for efficient immunoprecipitation. As an alternative, endogenous RBPs can be 249 
epitope-tagged, which can be achieved with the use of genome editing (Van Nostrand et al., 250 
2017a).  When using epitope-tagging, however, it is important to confirm that the function, 251 
stability and localisation of the tagged RBP remains unperturbed. 252 
The need for stringent purification and quality control varies depending on the type and 253 
expression of the RBP being studied. Some RBPs contain many single-stranded RNA binding 254 
domains; for example, ELAVL1 contains three RNA recognition motifs domains, and PTBP1 255 
contains four such domains. These domains recognise U-rich motifs, and are thus expected 256 
to crosslink efficiently. These RBPs are also typically expressed in high abundance. On the 257 
other hand, many RBPs lack canonical binding domains, or recognise the backbone of double-258 
stranded RNA. It has been shown that cysteine, tryptophan, phenylalanine, tyrosine, arginine, 259 
lysine and methionine are the most reactive (Shetlar et al., 1984), and thus RBPs lacking 260 
these amino acids in close proximity to the RNA base might crosslink poorly. Even a minor 261 
co-purification of another RBP that crosslinks with higher efficiency can lead to major loss of 262 
specificity, and this problem is exacerbated if the RBP-of-interest is of low abundance. Finally, 263 
some RBPs participate in stable RNPs that may not efficiently dissociate under standard CLIP 264 
immunoprecipitation conditions, thus increasing their risk of co-purifying multiple RBPs. 265 
In order to minimise the risk of co-purifying multiple RBPs, denaturing strategies are 266 
particularly valuable. Several epitopes enable denaturing and sequential purification 267 
strategies, which can further reduce the chance of co-purifying non-specific RBPs and RNAs. 268 
Denaturing purification was first implemented by CRAC for yeast, and later by CLAP, urea-269 
iCLIP, uvCLAP and dCLIP (Aktaş et al., 2017; Granneman et al., 2009; Huppertz et al., 2014; 270 
Rosenberg et al., 2017; Wang et al., 2010) (Table 1). Sequential histidine- and streptavidin-271 
based affinity purification systems are commonly used (Maticzka et al., 2017; Wang et al., 272 
2010), but immunoprecipitation is also possible if the antibody can bind to the denatured 273 
epitope. An example of an RBP that crosslinks poorly is the double-stranded RNA binding 274 
protein STAU1, which is prone to co-purification with other more abundant and strongly 275 
crosslinking RBPs and the RNAs crosslinked to them. Denaturing purification has been 276 
implemented with a 3xFlag-STAU1 and an anti-Flag antibody by using two rounds of 277 
immunoprecipitation, such that STAU1 was eluted after the first immunoprecipitation with a 278 
high concentration of urea, and then diluted to a lower concentration that enables the second 279 
round of immunoprecipitation (Huppertz et al., 2014). 280 
Adapter ligation 281 
To prepare cDNA libraries from the CLIP RNA fragments, they must contain common 282 
sequences complementary to the primers used in reverse transcription (RT) and PCR. Most 283 
CLIP protocols have a similar organisation of the sequenced reads (Fig. 1), therefore we have 284 
named the adapters according to their conventional orientation relative to sequencing. The 285 
exceptions are eCLIP and sCLIP (Kargapolova et al., 2017; Van Nostrand et al., 2016), where 286 
the orientation is switched (Table 1). The SeqRv adapter is complementary to the RT primer, 287 
and is ligated to the 3’ end of the RNA. The first version of the CLIP protocol ligates the 288 
adapters to purified RNA fragments (Ule et al., 2003), but most later variants perform on-bead 289 
RNA ligation, which reduces the amount of contaminating RNAs (Ule et al., 2005). On-bead 290 
ligation also allows removal of excess adapters by stringent washes of the beads instead of 291 
using denaturing acrylamide gel purification, thus minimising the loss of specific RNAs. An 292 
alternative to the ligation of an adapter to the 3’ end of the RNA is developed by sCLIP, where 293 
the purified RNAs are polyadenylated, followed by the use of modified oligo-dT primers for RT 294 
(Kargapolova et al., 2017). 295 
The original CLIP protocols ligated both adapters to the RNA fragments, which is also 296 
employed by HITS-CLIP and PAR-CLIP (Table 1, Table 2). This was modified by the iCLIP 297 
protocol, which ligates only the SeqRv adapter to the RNA. The SeqFw adapter, which was 298 
originally ligated to the 5’ end of RNA fragments in previous protocols, is introduced to the 5’ 299 
end of the RT primer and then brought to the 3’ end of the cDNA via circularisation in iCLIP 300 
(König et al., 2010). This enables amplification of cDNAs that prematurely truncate at the 301 
crosslinked nucleotide. These truncated cDNAs lack the SeqFw adapter in the original CLIP 302 
protocols, and are therefore lost. Beyond increasing the sensitivity of the experiment, the 303 
amplification of truncated cDNAs has an additional advantage by enabling nucleotide-304 
resolution mapping of the crosslink sites, which are located at the start of the great majority of 305 
iCLIP cDNA inserts (Haberman et al., 2017; Sugimoto et al., 2012). Since the development of 306 
iCLIP, 17 other published protocols similarly amplify truncated cDNAs, including BrdU CLIP, 307 
eCLIP, irCLIP and FLASH (Aktaş et al., 2017; Van Nostrand et al., 2016; Weyn-308 
Vanhentenryck et al., 2014; Zarnegar et al., 2016) (Table 1, Table 2, Table S1). The eCLIP 309 
protocol achieves this by ligating the SeqFw adapter to cDNAs with an intermolecular, rather 310 
than intramolecular ligation. 311 
Visualisation of the purified complexes on SDS-PAGE  312 
Visualisation of the protein-RNA complex is the central quality control step in CLIP. It serves 313 
to optimise RNA fragmentation, and to control for the specificity of purified complexes. 314 
Inclusion of this step guarantees the comparative value of CLIP data produced across the 315 
different RBPs, laboratories, and experimental settings. This step purifies the protein-RNA 316 
complexes with the use of SDS-PAGE and membrane transfer. The SDS-PAGE separation 317 
reduces contamination of non-crosslinked RNAs, which normally run at a lower range of the 318 
gel than the fragments crosslinked to the RBP. These are further removed by nitrocellulose 319 
membrane transfer, since the membrane has poor RNA-binding capacity. This also helps to 320 
remove excess adapters that can remain stuck on the beads after the RNA ligation step. 321 
Presentation of the resulting images from SDS-PAGE analysis alongside the publication of 322 
data ensures a quality control standard that has been established by the first publication of 323 
CLIP (Ule et al., 2003). 324 
In the original protocol, the 5’ end of the RNA is radioactively labelled with 32P in order to 325 
visualize the protein-RNA complexes after transfer to the membrane (Ule et al., 2003). This 326 
serves to control for the specificity of crosslinked RNAs, and to check that the RNA 327 
fragmentation conditions are appropriate (Ule et al., 2005). In certain cases, such as for Ago 328 
HITS-CLIP, where 5’ labelling is inefficient, a radiolabeled SeqRv adapter was ligated to the 329 
RNA to enable visualisation (Chi et al., 2009). Two RNA fragmentation conditions are 330 
recommended for the initial experiments. The high RNase condition serves to visualise the 331 
specificity of purified complex, since it migrates as a clear band slightly higher than the 332 
molecular weight (MW) of the immunoprecipitated RBP. To ensure the specificity of CLIP, no 333 
other bands should be visible near the expected band, since these bands indicate co-334 
purification of non-specific RBPs. The low RNase conditions, in contrast, serves to purify 335 
RNAs for preparation of the cDNA library. This condition should lead to complexes which 336 
migrate diffusely above the apparent MW of the immunoprecipitated RBP, since the diverse 337 
sizes of RNA fragments variably affects the migration of the RBP. The complexes are then 338 
excised from the appropriate region of the membrane according to the described 339 
recommendations (Huppertz et al., 2014; Ule et al., 2005). 340 
In the early versions of PAR-CLIP, the membrane transfer step is omitted and the RNA 341 
fragments are purified directly from the SDS-PAGE gel (Hafner et al., 2010). However, the 342 
developers included the option of performing the nitrocellulose membrane transfer in a more 343 
recent PAR-CLIP publication (Garzia et al., 2017). Recently, irCLIP has been developed for 344 
non-radioactive labelling of the purified protein-RNA complexes, increasing the convenience 345 
of this quality control step (Zarnegar et al., 2016). This is achieved by covalently coupling an 346 
infrared dye to the SeqRv adapter, which allows visualisation of the complexes after the SDS-347 
PAGE and transfer, with infrared imaging which can be performed with a LI-COR Odyssey 348 
CLx Imager. Since the infrared signal is present in the adapter that needs to be ligated to the 349 
RNA fragments, it additionally allows monitoring of on-bead adapter ligation efficiency. 350 
Another strategy for non-radioactive visualisation has been developed in sCLIP, where an 351 
aliquot of the immunoprecipitated sample is labelled with biotin-ADP and RNA ligase. The 352 
labelled and unlabelled fractions then proceed to SDS-PAGE and nitrocellulose transfer, 353 
followed by incubation of the membrane with streptavidin-HRP and ECL, in order to visualise 354 
the biotinylated RNA (Kargapolova et al., 2017). 355 
Several protocols omit the visualisation of purified complexes. One example is uvCLAP, which 356 
employs denaturing affinity purification, since the additional specificity gained by the 357 
denaturing step reduces the need for further purification by SDS-PAGE (Aktaş et al., 2017). 358 
The FLASH protocol also skips the SDS-PAGE and membrane transfer steps (Aktaş et al., 359 
2017), but unlike uvCLAP, it does not include denaturing affinity purification, which could 360 
compromise the specificity of data. In eCLIP and seCLIP, the SDS-PAGE and membrane 361 
transfer are used without labelling the RNA, and the RBP-RNA complexes are cut from the 362 
membrane by considering the MW of the RBP as observed on the IP-western performed in 363 
parallel and the predicted shift upwards on the gel due to the crosslinked RNA fragments (Van 364 
Nostrand et al., 2016, 2017b) (Table 1). 365 
While increasing the convenience, these protocols risk sacrificing the high specificity of the 366 
method. The specificity of purification conditions can be affected by many factors, including 367 
the cellular material and lysis conditions used, the type of RBP studied, and the stock and 368 
storage time of RNase and other reagents. Maintaining specificity is particularly challenging 369 
for studies of non-canonical RBPs that might crosslink weakly to RNA, or lowly expressed 370 
RBPs, since even a small amount of another co-purified RBP can lead to dominance of its 371 
crosslinked RNAs in the resulting libraries. We therefore advise that the SDS-PAGE 372 
visualisation is used at least initially to optimize the conditions for each RBP, in order to ensure 373 
that complexes are specific and that the RNase fragmentation conditions are appropriate. This 374 
allows the users to be confident in the consistent specificity and comparative value of CLIP 375 
data. When this step is omitted, additional computational quality control steps are crucial in 376 
order to evaluate the specificity of data (Chakrabarti et al., 2017). 377 
Reverse transcription (RT) 378 
After visualising the complexes on the nitrocellulose membrane, the appropriate region of the 379 
membrane is excised, and the RBP is digested with proteinase K, which leaves only a short 380 
peptide at the crosslink site and releases the RNA fragments into solution. The resulting RNA 381 
fragments are then available for RT with a primer that contains a sequence complementary to 382 
the SeqRv adapter. In iCLIP, additional sequences have been introduced to the tail of the RT 383 
primer. These include the SeqFw adapter, which is oriented in the opposite direction, an 384 
experimental barcode and the unique molecular identifier (UMI) (Fig. 1). The SeqFw adapter 385 
enables the later intramolecular ligation of the adapter to truncated and readthrough cDNAs; 386 
the experimental barcodes enable multiplexing of different cDNA reactions before proceeding 387 
to further steps; and the UMIs (which consist of a sequence of random nucleotides) enable 388 
quantification of unique cDNAs in combination with computational analysis that removes 389 
artefacts of variable PCR amplification (König et al., 2010). UMIs have also been introduced 390 
into the RNA SeqFw adapter in an early HITS-CLIP study (Chi et al., 2009), but explanation 391 
of its use for the analysis of sequencing data was only provided in later publications (Darnell 392 
et al., 2011; Moore et al., 2014). 393 
CLIP variants often use different RT enzymes and conditions, including the use of Superscript 394 
II, III or IV, AffinityScript and TGIRT. The impact of different RT conditions on cDNA truncation 395 
and readthrough has been recently investigated (Van Nostrand et al., 2017c).  The standard 396 
RT conditions primarily lead to truncation of cDNAs at the crosslinked nucleotide. This feature 397 
of the RT is well exploited by iCLIP and other protocols that ligate SeqFw adapter to cDNAs 398 
after reverse transcription, as they rely on the truncated cDNAs for precise mapping of the 399 
crosslinked nucleotide position. However, use of manganese instead of magnesium ions in 400 
the buffer can increase the efficiency of readthrough, especially when used in combination 401 
with Superscript IV, and this could benefit techniques that rely on readthrough cDNAs, such 402 
as the original CLIP or PAR-CLIP. While most enzymes produce similar cDNA truncation, the 403 
position of truncation may be offset by one nucleotide when AffinityScript (used in eCLIP), is 404 
compared to other enzymes such as Superscript (used in iCLIP and most other protocols) 405 
(Van Nostrand et al., 2017c). This needs to be further examined by comparing the position of 406 
crosslink sites assigned with eCLIP and iCLIP for multiple different RBPs.  407 
cDNA purification and amplification 408 
In the original CLIP or iCLIP protocols, gel purification is used to purify the RNA fragments or 409 
cDNAs, respectively (König et al., 2010; Ule et al., 2003). The primary purpose is to remove 410 
free adapters or RT primers, which would otherwise become templates for reverse 411 
transcription or PCR. Carry-over of excess adapters can lead to cDNA libraries that are 412 
dominated by PCR artefacts which contain only the barcode or adapter sequences. However, 413 
gel purification, phenol-chloroform extractions and ethanol precipitations can be laborious, 414 
especially in large-scale experiments. In recent years, several independent approaches have 415 
been developed to replace the gel purification steps with approaches that increase the 416 
convenience and speed of CLIP protocols, as well as minimising loss of material. These 417 
approaches can be separated conceptually into two types: the first captures nucleic acids 418 
above a certain size range with the use of silica-like beads or columns; the second specifically 419 
captures the cDNAs via an incorporated molecule, such as BrdU in BrdU CLIP, or a 420 
biotinylated SeqRv adapter that remains annealed to the cDNA in FAST-iCLIP (Aktaş et al., 421 
2017; Flynn et al., 2015; Kargapolova et al., 2017; Van Nostrand et al., 2016; Weyn-422 
Vanhentenryck et al., 2014; Zarnegar et al., 2016) (Table 1, Table 2). It remains to be seen 423 
which of these variant solutions will be most broadly adopted; the ideal solution should be 424 
practical, while efficiently capturing all specific cDNAs without any bias in cDNA size or 425 
sequence, in order to maximize the sensitivity of CLIP. 426 
While less convenient, gel extraction provides the most precise size selection of RNA 427 
fragments or cDNAs of defined length, thus mitigating potential variations in cDNA length 428 
distribution in the final library, and ensuring that adapter products are completely removed 429 
prior to PCR. To compensate for this, methods such as FAST-iCLIP and eCLIP that omit gel 430 
extraction before PCR often employ an additional gel extraction of the final PCR-amplified 431 
cDNA libraries (Flynn et al., 2015; Van Nostrand et al., 2016). Loss of material is not a major 432 
concern at this step, since many copies of each cDNA are available due to amplification. 433 
However, this approach could be prone to amplifying adapter artefacts in situations where the 434 
amount of specific cDNA is limiting, for example when studying an RBP that crosslinks poorly. 435 
For PCR amplification of cDNAs, most recent methods use enzymes that are slightly more 436 
efficient than the Accuprime enzymes that were used by the original protocols. The switch to 437 
the Phusion enzyme allows amplification of the final cDNA library with a decreased number of 438 
PCR cycles, in our hands, without much impact on the data quality (data not shown). In 439 
general, while a reduced number of PCR cycles required for cDNA amplification is a promising 440 
sign, it should be interpreted cautiously, since it can be due to either an increase in sensitivity 441 
or a decrease in specificity. For example, reduced PCR cycle numbers could arise from the 442 
increased co-purification of non-specific RBPs and their crosslinked RNAs. When the SDS-443 
PAGE quality control analysis is omitted, one cannot distinguish between these two 444 
possibilities. 445 
Primary data analysis and sequencing requirements 446 
The first step in analysing sequencing data produced by CLIP is to examine the experimental 447 
barcodes to demultiplex the cDNA libraries, which is followed by mapping the data to the 448 
genome. For iCLIP and the 17 later protocols that introduce UMIs into cDNAs (Table 2, Table 449 
S1), this can be used to quantify unique cDNAs that map to same loci on the genome without 450 
ambiguity. The results can then be exploited by using the full position of mapped reads as in 451 
HITS-CLIP (Licatalosi et al., 2008), or by identifying the most likely position of the crosslink 452 
site, which can be achieved in three ways. PAR-CLIP examines C to T transitions in reads 453 
(Hafner et al., 2010), iCLIP (and 17 other protocols) examines cDNA truncations (König et al., 454 
2010), and crosslinking-induced mutation sites (CIMS) in HITS-CLIP reads examines 455 
deletions and other types of mutations (Zhang and Darnell, 2011). Interestingly, analysis of 456 
cDNA truncations was found to be most appropriate for the protocol that crosslinks cells with 457 
4SU as in PAR-CLIP, but then uses iCLIP to prepare the cDNA library (4SU-iCLIP) (Haberman 458 
et al., 2017).  459 
Single-end sequencing is appropriate for iCLIP and several derived protocols (such as irCLIP), 460 
because both the experimental barcode and UMI are present at the start of the trimmed 461 
sequencing read (Fig. 1). The start of the cDNA insert contains information for the crosslink 462 
site; the end of the cDNA insert corresponds to the position of RNA cleavage, which is useful 463 
to assess biases of RNA fragmentation (Haberman et al., 2017), but is otherwise not crucial 464 
for data analysis. However, several protocols introduce important information at both sides of 465 
the cDNA inserts, which requires paired-end sequencing, or long-read single-end sequencing 466 
that covers the whole cDNA insert. This applies to eCLIP and sCLIP, where the cDNA insert 467 
is inverted relative to orientation of sequencing; hence the crosslink site needs to be 468 
sequenced from the reverse direction (Kargapolova et al., 2017; Van Nostrand et al., 2016). 469 
uvCLAP and FLASH protocols also use paired-end sequencing, where a part of the 470 
experimental barcode and UMI are introduced by the SeqRv adapter, and are therefore 471 
positioned at the end of the cDNA insert (Aktaş et al., 2017; Garzia et al., 2017). However, 472 
single-end eCLIP (seCLIP) has been recently described, which reverts to the iCLIP-like read 473 
structure compatible with shorter single-end sequencing (Van Nostrand et al., 2017b). 474 
Sequencing of long reads is also beneficial for protocols where the full read or internal 475 
mutations are used for analysis, such as HITS-CLIP and PAR-CLIP, as it allows to fully 476 
quantify the internal mutations in cDNAs. 477 
Analysis of quality and normalisation of CLIP data 478 
In addition to visualising the purified protein-RNA complexes during the CLIP protocol, the 479 
quality of the resulting data can also be examined computationally. Many parameters can be 480 
considered to compare the effectiveness of CLIP-derived methodologies, with sensitivity and 481 
specificity being the two central measures. The simplest measures of sensitivity and specificity 482 
are the number of unique cDNAs in the sequencing library, and clusters of significant 483 
crosslinking events (‘peaks’), respectively (Chakrabarti et al., 2017).  484 
To monitor the sensitivity of CLIP, the capacity to quantify unique cDNAs with the use of UMIs 485 
is particularly valuable. This is because UMIs distinguish unique cDNAs from those that have 486 
been duplicated as a result of PCR amplification. In addition, the ratio of unique versus 487 
duplicated cDNAs is also a useful measure to assess whether the depth of sequencing was 488 
optimal, and thereby inform on the conditions for most cost-effective sequencing. 489 
To monitor the specificity of CLIP, a suitable peak-calling program needs to be chosen 490 
according to the CLIP protocol used to produce the data (Chakrabarti et al., 2017). A low 491 
number of peaks indicates that the cDNAs are randomly dispersed along the transcripts, or 492 
that they are concentrated in a small number of abundant RNAs (such as rRNA). However, 493 
these features could reflect true binding preferences of the RBP that is studied, since many 494 
RBPs don’t recognise specific sequence or structural RNA motifs (Jankowsky and Harris, 495 
2015), and therefore the number of crosslink peaks is only a rough approximation of specificity. 496 
For example, proteins such as FUS or SUZ12 have been shown to have low sequence 497 
preference, and therefore their crosslink sites are broadly dispersed across nascent RNAs 498 
(Beltran et al., 2016; Rogelj et al., 2012) and rarely lead to crosslink peaks. Nevertheless, 499 
analysis of crosslink peaks is particularly valuable to compare multiple data sets for the same 500 
RBP. For example, data produced by iCLIP of PTBP1 led to a larger number of peaks than 501 
data produced by other protocols, even though the number of unique cDNAs in iCLIP is equal 502 
or smaller, and this agrees with highest motif enrichment in iCLIP peaks, especially when 503 
compared with irCLIP (Haberman et al., 2017). 504 
To normalise the binding patterns relative to RNA abundance, input control libraries that have 505 
not undergone immunoprecipitation can be produced (Ule et al., 2005). Here, the lysate of 506 
crosslinked cells after treatment with RNase is loaded on the gel and transferred to the 507 
membrane. The RNAs that crosslink to all RBPs present in a selected section of the 508 
membrane are isolated and their cDNA library is prepared in the same way as for specific 509 
RBPs. This has been exploited for an approach to analyse eCLIP data, which filters the sites 510 
that are not significantly enriched compared to the size-matched input (SMInput) control (Van 511 
Nostrand et al., 2016, 2017d). This approach can help to enrich the high-affinity binding sites 512 
relative to low-affinity transient interactions, both of which can be detected by CLIP. 513 
However, neither definition of crosslink clusters, nor the normalisation by SMInput control can 514 
ensure the specificity of CLIP data. Presence of non-specific RNAs in CLIP is most often 515 
introduced via co-purification of one RBP or a small number of RBPs, along with their 516 
crosslinked RNAs. Since these non-specific RNAs were bound by the co-purified RBPs, they 517 
can lead to the identification of distinct binding peaks that are strongly enriched compared to 518 
the SMInput control, and can have clear motif enrichment. Therefore, the ideal way to validate 519 
the specificity of CLIP data is to experimentally visualise the quality of purified RBP-RNA 520 
complexes on SDS-PAGE. Moreover, integrative computational analyses that use orthogonal 521 
functional information can be used, such as comparison with motifs known to be bound by 522 
immunoprecipitated RBP (Haberman et al., 2017). In addition, the metaprofile of binding sites 523 
can be visualised around exons or other RNA landmarks that are regulated by the RBP, and 524 
compared with non-regulated exons, which is commonly referred to as RNA maps. These 525 
approaches, and other methods and databases for computational analysis of CLIP data are 526 
discussed in detail elsewhere (Chakrabarti et al., 2017). 527 
 Conclusion and future perspectives 528 
The large number and modularity of steps in CLIP provides many opportunities for innovation, 529 
and new purposes to which the method can be applied continue to be discovered. While the 530 
initial development of CLIP was led primarily by the desire for stringent purification and quality 531 
control standards, the more recent methods prioritise speed and convenience. This improves 532 
the capacity for high-throughput studies of many RBPs across many types of conditions, 533 
tissues or species. The use of modified UV illuminators and high-performance UV lasers that 534 
can crosslink proteins to RNA in vivo in seconds can also improve the capacity to monitor the 535 
dynamics of protein-RNA complexes at high temporal resolution (van Nues et al., 2017).  536 
While these modifications are generally beneficial, common standards for quality control 537 
should be maintained to allow robust comparisons between datasets. We note that current 538 
publically available data from CLIP experiments are generated with protocols that employ 539 
varying stringencies of RBP purification, and depending on the stability of the RNP complexes, 540 
this results in data of variable specificity. Thus, quality measures of specificity will be important 541 
to have a clear interpretation of whether the data represents specific isolation of direct binding 542 
sites for the RBP-of-interest, or rather just an enrichment of such sites (Chakrabarti et al., 543 
2017). The visualisation of SDS-PAGE-separated protein-RNA complexes and computational 544 
tools for quality analysis of sequenced CLIP libraries will be particularly valuable. Comparison 545 
with methods that do not rely on protein purification or crosslinking to identify RNAs interacting 546 
with RBPs in vivo, such as RNA tagging or TRIBE (targets of RNA-binding proteins identified 547 
by editing) (Lapointe et al., 2015; McMahon et al., 2016), could also prove valuable in the 548 
interpretation of CLIP data. 549 
In addition to studies of endogenous protein-RNA complexes, variants of CLIP have also been 550 
put to other purposes (Table 1). This includes studies of intermolecular or intramolecular RNA-551 
RNA contacts (Chi et al., 2009; Imig et al., 2015; Kudla et al., 2011; Sugimoto et al., 2015), as 552 
reviewed in more depth elsewhere (Sugimoto et al., 2017). Moreover, CLIP of poly(A)-binding 553 
protein (PABP) can be exploited to study mRNA 3’ ends (Hwang et al., 2016); recently, cell-554 
type specific expression of PABP has been engineered in the mouse brain, thus allowing the 555 
study of cell type specific transcripts (Hwang et al., 2017). Moreover, iCLIP has been adapted 556 
for studies of RNA methylation, as in m5C- and m6A-miCLIP (Hussain et al., 2013; Linder et 557 
al., 2015). These methods could be applied also to other modifications with the use of further 558 
antibodies and mutant enzymes, thus broadening the use of CLIP for the epitranscriptomic 559 
field. Together, the rapidly increasing amount of CLIP data for many RBPs from the ENCODE 560 
consortium and other teams, and the orthogonal methods that interrogate the specificity, 561 
functions and localisation of these RBPs (Van Nostrand et al., 2017d), will enable the study of 562 
how structure and modifications on diverse types of RNAs work together with RBPs to guide 563 
RNP assembly, dynamics and function. 564 
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  785 
Figure Legends 786 
Figure 1: The core steps of iCLIP and other variants of CLIP.  787 
The majority of currently available CLIP protocols (18 out of 28, Table S1) amplify truncated 788 
cDNAs to identify the protein-RNA crosslink sites. Therefore, this schematic follows the core 789 
steps of iCLIP, a variant that was developed to amplify truncated cDNAs. The structure of 790 
RNA fragments, cDNA inserts, and sequenced reads is marked along with colour-coded 791 
adapters, unique molecular identifiers (UMI), experimental barcodes and primers. The 792 
adapters are named as SeqRv and SeqFw, according to their conventional orientations 793 
relative to the final sequenced reads. Where indicated, variations introduced by other CLIP 794 
protocols are illustrated.  795 
Table 1: List of CLIP and related protocols 796 
Protocols are ordered by the year of publication to reflect their historical development. 797 
Updated publications introducing important variations to the same method are grouped with 798 
the initial publication. Protocols that are not aimed at studying the specif icity of an RBP, but 799 
that apply the CLIP technology to a new purpose, are listed at the end. 800 
Table 2: The core steps of CLIP and their variations 801 
The 11 core steps of the CLIP are listed, as well as the primary variations made in each step 802 
over the last 15 years, along with the names and publication dates of protocols that first 803 
introduced each variation. The number of CLIP protocols from the list in Table 1 and the 804 
number of developer labs that adopted each variant is shown, with the full list behind these 805 
numbers available in Table S1. A description and explanation of the rationale behind each 806 
variation is provided. 807 
Table S1. Related to Figure 1 and Table 2: Adopted variations in published CLIP protocols 808 
For all CLIP variants listed in Table 1, the variations adopted by each specific protocol are 809 
annotated. Boxes in black apply when none of the variants of the corresponding step are 810 
implemented by a protocol. 811 
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Table1
Acronym Full Name Citation of Protocol
RIP RNA immunoprecipitation Lerner and Steitz, 1979
Ule et al., 2003 
Ule et al., 2005
Fractionation CLIP CLIP from nucleus, cytosol and polysomes Sanford et al., 2008
Licatalosi et al., 2008
Chi et al., 2009
CLIP-seq CLIP coupled with high-throughput sequencing Yeo et al., 2009 
CRAC UV cross-linking and analysis of cDNAs Granneman et al., 2009
Hafner et al., 2010
Garzia et al., 2017
iCLIP Individual-nucleotide resolution CLIP König et al., 2010
CLAP Crosslinking and affinity purification Wang et al., 2010
4SU-iCLIP 4SU-mediated crosslinking followed by iCLIP Huppertz et al., 2014
urea-iCLIP iCLIP with denaturing purification Huppertz et al., 2014
BrdU CLIP Bromodeoxyuridine UV CLIP Weyn-Vanhentenryck et al., 2014
FAST-iCLIP Fully automated and standardized iCLIP Flynn et al., 2015
irCLIP Infrared-CLIP Zarnegar et al., 2016 
eCLIP Enhanced CLIP Van Nostrand et al., 2016 
seCLIP Single-end eCLIP Van Nostrand et al., 2017c 
uvCLAP UV crosslinking and affinity purification Aktaş et al., 2017 
FLASH Fast ligation of RNA after some sort of affinity purification for high-throughput sequencing Aktaş et al., 2017 
Fr-iCLIP Fractionation iCLIP Brugiolo et al., 2017
sCLIP Simplified CLIP Kargapolova et al., 2017
dCLIP Denaturing CLIP Rosenberg et al., 2017
CLASH Cross-linking, ligation, and sequencing of hybrids Kudla et al., 2011
hiCLIP RNA hybrid and iCLIP Sugimoto et al., 2015 
PAPERCLIP Poly(A) binding protein-mediated mRNA 3'end retrieval by CLIP Hwang et al., 2016 
cTag-PAPERCLIP "Conditionally" tagged-PAPERCLIP Hwang et al., 2017 
m5C-miCLIP Cytosine-5 methylation iCLIP Hussain et al., 2013 
m6A-miCLIP N6-methyladenosine iCLIP Linder et al., 2015 
Further applications of CLIP
CLIP and related protocols
CLIP (UV) Crosslinking and immunoprecipitation
HITS-CLIP High-throughput sequencing of RNA isolated by CLIP
PAR-CLIP Photoactivable ribonucleoside-enhanced CLIP
Core steps and their 
variations in CLIP 
protocols
Number of 
protocols 
(developer 
labs)
First protocol 
developing the 
variation
Description and rationale for each step and its variations
UV-C crosslinking of intact 
cells or tissues 23 (11) CLIP (2003)
UV-C crosslinking (254nm) can be applied on any type of sample, including postmortem human 
tissues, and its efficiency is generally similar to the use of UV-A with 4SU.
UV-A crosslinking of cells 
after incubation with 
photoactivatable 
ribonucleosides
3 (2) PAR-CLIP (2010)
UV-A crosslinking (365nm) requires preincubation of cells with 4SU or 6SG. It can lead to 
preferential identification of those protein-RNA contact sites that contain U or G, and long 
preincubation with 4SU or 6SG can lead to cellular stress (Huppertz et al., 2014). It increases 
efficiency for some RBPs, and is likely to be particularly valuable for studies of RBP interactions with 
nascent RNAs.
Mutation-induced 
crosslinking 1 (1)
m5C-miCLIP 
(2013)
This method employs a mutant RNA methylase, NSun2, which forms a covalent bond with its m5C 
methylated base.
In vitro UV-C crosslinking 
of antibody to purified RNA 1 (1)
m6A-miCLIP 
(2015)
RNAs are purified from cells and fragmented. The RNA fragments are then incubated with m6A 
specific antibody. Captured RNA fragments are crosslinked to the antibody with UV-C. 
Total cell 25 (11) CLIP (2003) RBP is purified from total cellular lysate, which enables to simultaneously examine all types of RNAs bound by an RBP in all cellular compartments.
Fractionation 
CLIP (2008)
RBP is purified from cellular subcompartments. The basic approach is to fractionate crosslinked 
cells into nuclear and cytosol fractions, and here polysomes are studied in addition.
fr-iCLIP (2017) Here, nucleoplasm and chromatin are studied in addition to cytosol.
RNase digestion in lysate 23 (10) CLIP (2003) RNA fragmentation in the lysate ensures that RNA-dependent RNP complexes dissociate before incubation with the beads, thus avoiding co-purification of additional RBPs.
Controlled RNA 
fragmentation by 
optimising limited RNAse 
digestion
21 (9) CLIP (2005)
The procedure for optimising limited RNAse digestion is presented by using gel shift analysis of 
protein-RNA complexes separated by SDS-PAGE. This is important to A) Ensures that the final 
cDNAs are long enough to enable unique genomic mapping. B) Overdigestion introduces sequence 
constraints and biases due to preferred RNase cleavage patterns (Haberman et al., 2017). C) Avoid 
insufficient RNase digestion, which could keep larger RNPs intact, thus leading to co-purification of 
non-specific RBPs and RNAs.
Use of RNase I 12 (6) iCLIP (2010)
Most RNases preferentially cleave after one or two specific nucleotides. RNase I is capable of 
cleaving at all nucleotides, and thus has less sequence specificity than other RNases. This 
minimises the sequence bias of RNA fragmentation, thus decreasing the sequence constraints at 
cDNA ends (Haberman et al., 2017).
PAR-CLIP (2010)
In addition to RNase digestion in lysate, a second round of RNase digestion is performed on beads. 
This leads protein-RNA complexes migrating as a sharp band on SDS-PAGE, indicative of RNA 
overdigestion that can lead to short reads which may not map uniquely to the genome.
irCLIP (2016)
On-bead RNase digestion allows the use of nuclease S1, a less efficient enzyme that is not 
compatible with in-lysate digestion. Nuclease S1 leaves a 3'OH group on RNA fragments, which is 
convenient by avoiding the need for an additional phosphatase step. However, the on-beads 
digestion might be less efficient in dissociating large RNP complexes.
In vitro  fragmentation of 
purified RNA 1 (1)
m6A-miCLIP 
(2015) Purified RNAs are fragmented by zinc(III)-mediated RNA cleavage.
Immunoprecipitation under 
mild conditions RIP (1979)
RNA immunoprecipitation, in its original version, is performed without RNAse, and under conditions 
that are mild enough to preserve protein binding to the RNA targets without any crosslinking. This 
serves to identify RNAs enriched in the immunoprecipitation, rather than to define the position of 
binding sites.
Immunoprecipitation under 
stringent conditions 21 (10) CLIP (2003)
Stringent washing with high salt buffers and ionic detergents preserves only the crosslinked protein-
RNA contacts, followed by SDS-PAGE and membrane transfer to further separate any remaining co-
purified proteins that are of different MW. Nitrocellulose membrane does not bind well to nucleic 
acids, thus allowing to further remove any remaining free RNAs.
CRAC (2009)
Uses two-step affinity purification of tagged proteins in yeast under denaturing conditions to 
completely remove any interacting RBPs and free RNAs that are not crosslinked to the protein of 
interest.
CLAP (2010)
Like CRAC, but uses two-step affinity purification of tagged proteins in mammalian cells under 
denaturing conditions. Relies on 8xHis- and two Strep-tag II peptides. While ensuring specificity, the 
method requires expression of tagged proteins, which may not fully reflect the binding pattern of 
untagged endogenous proteins.
urea-iCLIP 
(2014)
Like CLAP, but using a 3xFlag-tag, such that the RBP is eluted after the first immunoprecipitation 
with denaturing conditions (eg. high SDS or urea and heat), which is then followed by a second 
immunoprecipitation.
uvCLAP (2017) Like CLAP, but replacing the 8xHis- and Strep-tag with 3xFlag-tag and histidine-biotin-histidine-tagging.
dCLIP (2017)
RBP is fused with a biotinylation tag, which enables it to be biotinylated in cell lines expressing the 
bacterial biotin ligase BirA. The RBP is then purified with streptavidin beads and subjected to 
multiple denaturing 8M urea and 2% SDS washes.
Ligation to purified RNA 4 (3) CLIP (2003)
In the original protocol, adapters are ligated to RNA after membrane transfer and digestion of the 
protein. This requires an additional gel purification to remove the adapter, which leads to some loss 
of RNA. This protocol can also be prone to amplifying non-specific bacterial or yeast RNAs that can 
be introduced as contaminants during PAGE or transfer of the protein-RNA complexes, and adapter-
adapter concatamer artefacts. The protocol can be of use in rare cases where on-bead ligation is 
inefficient.
On-bead ligation 23 (10) CLIP (2005)
On-bead ligation allows removal of the adapter by washing the beads, and free adapters are further 
removed by SDS-PAGE and transfer. Thus no additional step is needed to remove the adapter. The 
on-beads ligation is efficient when used with magnetic beads, as long as the RNA fragments are 
>15nt and the relative volume of beads vs. ligation reaction is appropriate. Its efficiency needs to be 
tested when changing the type of beads used.
Fractionated cells 3 (3)
4. Purification of protein-RNA complexes
Denaturing purification with 
the use of epitope tags
5. Ligation of SeqRv adapter to fragmented RNA
6 (4)
1. Covalent protein-RNA crosslinking
2. Cell lysis
3. RNA fragmentation
On-bead RNase digestion 5 (4)
Barcoded seqRv adapter 4 (3) eCLIP (2016), uvCLAP (2017)
Allows multiplexing of experiments immediately after IP, which can save time and reduce 
experimental variation between samples. However, this loses the capacity to examine the specificity 
of purified protein-RNA complexes during the membrane visualisation step. It also requires PE 
sequencing or long sequencing reads, in order to ensure that the full cDNA together with the 
barcode in the SeqRv adapter are sequenced.
Polyadenylation of purified 
RNAs 1 (1) sCLIP (2017)
Instead of ligating SeqRv, the purified RNA fragments are polyadenylated, and the poly(A) tail is 
then used as the template for annealing the RT primer.
Visualisation of PAGE-
separated protein-RNA 
complexes
24 (11) CLIP (2003)
Allows visualisation and validation of the specificity of the protein-RNA complexes, to confirm 
absence of non-specific co-purified RBPs or RNAs, and to demonstrate that RNase conditions are 
well optimised. The original protocol used radioactive 5' end labelling of RNA fragments for this 
purpose.
irCLIP (2016) Infrared signal is introduced via a dye-coupled SeqRv adapter, which allows visualisation of protein-RNA complexes without the use of radioactivity, while also monitoring ligation efficiency. 
sCLIP (2017) An aliquot of the immunoprecipitation is labelled by conjugating biotin-ADP to the 3' end of the crosslinked RNAs. Subsequently this is visualised with streptavidin-HRP chemiluminescence. 
Proteinase digestion 28 (13) CLIP (2003)
Proteinase K (PK) is used to cleave the protein crosslinked to RNA under denaturing conditions. 
This releases the RNA into solution, along with a small peptide that remains on the RNA at the 
crosslink site.
Use of SDS buffer 5 (4) CRAC (2009) Both urea and SDS denature proteins and enhance PK activity, but urea can be unstable upon prolonged storage, and therefore SDS is proposed to be used instead.
Conversion of RNA 
fragments into cDNAs 28 (13) CLIP (2003) A primer complementary to the SeqRv adapter is used to convert RNA fragments into cDNAs.
Introduction of 
experimental barcodes and 
unique molecular 
identifiers (UMIs) into 
cDNAs
15 (7) iCLIP (2010)
UMIs (also referred to as random barcodes, or randomers) allow to quantify the number of unique 
cDNAs that map to the same position in the genome, thus differentiating them from PCR amplicons 
of the same cDNA molecule, taking full advantage of highthroughput sequencing to the quantify 
cross-linking at specific nucleotides.
Denaturing acrylamide gel 
purification of ligated RNAs 3 (2) CLIP (2003)
This step has been used by protocols that ligated both seqRv and seqFw adapters to the purified 
RNA in order to remove the adapters. After RT-PCR, the cDNA undergoes further size selection.
TBE-Urea acrylamide gel 9 (4) iCLIP (2010)
Excess RT primers are removed with gel purification, which also serves to select specific cDNA size 
ranges as an additional quality control. This is followed by ethanol precipitation. Under optimal 
conditions, recovery is ~90%, but the method requires some experience to avoid carrying over salts 
or any other reagents that could inhibit PCR.
BrdU capture 3 (1) BrdU CLIP (2014)
Br-dUTP replaces dTTP in the reverse transcription reaction, enabling purification of cDNAs by two 
rounds of immunoprecipitation with an anti-BrdU antibody. During the second round, cDNAs are 
circularised and linearised as in iCLIP, and then eluted by heating.
Fast-iCLIP 
(2015)
Streptavidin purification of cDNA is enabled via biotinylated SeqRv that has been ligated to RNA, 
and remains attached to cDNAs. After circularisation, cDNA is eluted from the streptavidin beads 
and column purified. This increases the convenience and speed of the protocol. After PCR 
amplification, cDNAs are then size-selected with acrylamide gel.
irCLIP (2016) Similar to Fast-iCLIP, but after circularisation, cDNA is incubated with isopropanol and AMPure beads for further purification and size selection of cDNA.
Silane beads purification of 
cDNA 2 (1) eCLIP (2016)
After enzymatic degradation of free RT primers with Exo-SAP, cDNA is purified with silane beads, 
and after PCR amplification, further purified with native agarose gel.
FLASH (2017) After RT, cDNA is column purified. There are no further purification steps after circularisation.
sCLIP (2017) After RT, the protocol employs second strand cDNA synthesis, in vitro  transcription, and adapter ligation to the antisense RNA, each coupled with column-based purification steps.
SeqFw adapter is ligated to 
the 5' end of RNA 
fragments
9 (5) CLIP (2003)
SeqFw adapter is required to amplify cDNAs. Since it is ligated to the 5' ends of RNA fragments, the 
full RNA fragment needs to be reverse transcribed in order to create amplifiable cDNAs in CLIP. 
Therefore, only cDNAs that read through the crosslinked nucleotide can be amplified by PCR, 
leading to loss of truncated cDNAs.
iCLIP (2010)
Ligation of SeqFw to cDNA is achieved by introducing the seqFw sequence into cDNAs via the RT 
primer, followed by its efficient intramolecular ligation to the 3' end of cDNAs with the use of 
circligase. The circular cDNA is then linearised through a BamHI site in the RT primer, which then 
enables amplification and sequencing of both 'read-through' and 'truncated' cDNAs. When 
combined with analysis of clustered cDNA starts, this allows to map the position of the high-
occupancy cross-linking with nucleotide resolution. 
Fast-iCLIP 
(2015)
As iCLIP, except that RT primer contains two carbon spacers between the SeqFw and SeqRv 
sequences, which allow termination of the PCR enzyme, thus removing the need for BamHI 
digestion.
eCLIP (2016) The cDNA circularisation is replaced by an intermolecular ligation of SeqFw with the use of RNA ligase.
cDNA cloning and Sanger 
sequencing 4 (3) CLIP (2003) Individual cDNAs are cloned for Sanger sequencing.
HITS-CLIP 
(2008)
Overhangs are added to PCR primers, which include experimental barcodes for each sample and 
sequencing adapters, which allows multiplexing of the cDNA libraries and high-throughput 
sequencing.
Fast-iCLIP 
(2015)
Phusion enzyme is used for PCR, and qPCR is used to determine the optimal number of PCR 
cycles.
18 (8)
25 (12)
9. cDNA purification
10. SeqFw adapter ligation
SeqFw adapter is ligated to  
3' end of cDNAs to enable 
amplification of truncated 
cDNAs
11. cDNA amplification and sequencing of multiplexed libraries
High-throughput 
sequencing of multiplexed 
cDNA libraries
Streptavidin beads 
purification of cDNA
Column purification of 
cDNA
2 (1)
2 (2)
Non-radioactive 
visualisation of protein-
RNA complexes
7. RNA extraction
8. Reverse transcription
2 (2)
6. Quality control 
